A Study to Compare Efficacy and Safety of CT-P55 and Cosentyx in Patients With Moderate to Severe Psoriasis

NCT06630559 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

153

Enrollment

INDUSTRY

Sponsor class

Conditions

Plaque Psoriasis

Interventions

BIOLOGICAL: CT-P55
BIOLOGICAL: EU-approved Cosentyx

Sponsor

Celltrion